Repros Therapeutics Inc. ( RPRX ) announced it has completed enrollment for one of the two head to head studies …read more

Merck ( MRK ) presented interim data from an ongoing phase II study on its once daily, all oral hepatitis …read more

SINA Corp ( SINA ) recently approved a new share repurchase program worth approximately $500.0 million. SINA’s management expects to …read more

On April 11, Zacks Investment Research upgraded Quest Diagnostics Inc. ( DGX ) to a Zacks Rank #2 (Buy) from …read more

Pipeline updates are highly awaited events in the pharma biotech sector as they play an important role in deciding whether …read more

On Apr 10, 2014, we issued an updated research report on the real estate investment trust (REIT) Liberty …read more

Linear Technology Corporation ( LLTC ) is set to report third quarter fiscal 2014 results on Apr 15. Last quarter, …read more

Integrated oil and gas company TOTAL S.A. ( TOT ) is set to expand its footprint in Africa by developing …read more

General Motors Co. ( GM ) has been facing tough times lately due to a series of vehicle recalls. Recently, …read more

AbbVie ( ABBV ) presented positive data from a phase III study, TURQUOISE II, on its investigational hepatitis C virus …read more